Comments on the “2017 Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups”. Points of Concern

Arthritis and Rheumatology - United Kingdom
doi 10.1002/art.40478
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Response to Comments on the “2017 EULAR/ACR Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups”. Points of Concern

Arthritis and Rheumatology
RheumatologyAllergyImmunology
2018English

Progress Report on Development of Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies

Pediatric Rheumatology
ImmunologyPediatricsRheumatologyAllergyPerinatologyChild Health
2014English

Management of the Idiopathic Inflammatory Myopathies

Prescriber
Pharmacology
2019English

Development of a New Classification System for Idiopathic Inflammatory Myopathies Based on Clinical Manifestations and Myositis-Specific Autoantibodies

JAMA Neurology
Neurology
2018English

Drugs in Induction and Treatment of Idiopathic Inflammatory Myopathies

Autoimmunity Highlights
RheumatologyImmunology
2014English

Idiopathic Inflammatory Myopathies Overlapping With Systemic Diseases

Clinical Neuropathology
MedicineForensic MedicinePathologyNeurology
2018English

Modern Therapies for Idiopathic Inflammatory Myopathies (IIMs): Role of Biologics

Clinical Reviews in Allergy and Immunology
MedicineAllergyImmunology
2016English

Juvenile Idiopathic Arthritis and Uveitis: The Classification Conundrum

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2000English

Anti-HMGCR Autoantibodies in Juvenile Idiopathic Inflammatory Myopathies Identify a Rare but Clinically Important Subset of Patients

Journal of Rheumatology
RheumatologyAllergyImmunology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy